Six days following vaccination with MCMVgp100KGP, PMEL cells within the tumor microenvironment expressed high levels of the inhibitory receptors LAG3, PD-1, and NKG2A compared to PMEL cells in the blood (Figure 5). This evidence concerns the gene KLRC1 and neoplasm.